arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

PRO DEX INC

PDEX
$61.28 ▼ -4.70 (-7.13%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
72
Health
Good
Bullish
auto_awesome

Analytical Summary

PRO DEX INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $197.7M
Dividend Yield —
Revenue Growth 16.5% ↘
Op. Margin 16.8% ↗
ROIC 15.1% ↘
FCF / Share $2.10 ↗
Trailing P/E 14.5x
Price / Book 4.1x
FCF Yield 3.4%
Debt / Equity 0.37
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$77.55M
↑ +16.5% —
Net Income Profit after all expenses
$13.66M
↑ +52.2% —
Operating Margin Operating profit as % of sales
16.8%
↑ +4.4% 80th
FCF / Share Free cash flow per share
$2.10
↑ +335.3% —
Long-Term Debt Long-term obligations
$17.51M
↑ +46.5% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
73
Returns ↑
89
Financial Health →
67
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 66 quarters